ArticleBMJ open2024

Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study.

Akiko KowadaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.